REFERENCES
  1. World Health Organization. Adherence to long-term therapies: evidence for action. 2003. https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf. Accessed 13 Jan 2022.
  2. Brown MT, Bussell J, Dutta S, Davis K, Strong S, Mathew S. Medication adherence: truth and consequences. Am J Med Sci. 2016;351:387-99. https://doi.org/10.1016/j.amjms.2016.01.010.
  3. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97. https://doi.org/10.1056/nejmra050100.
  4. Matsui D. Adherence with drug therapy in pregnancy. Obstet Gynecol Int. 2012;2012:796590. https://doi.org/10.1155/2012/796590.
  5. Widnes SF, Schjøtt J, Eide GE, Granas AG. Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets. Drug Saf. 2013;36:481-9. https://doi.org/10.1007/s40264-013-0035-9.
  6. Amundsen S, Øvrebø TG, Amble NMS, Poole AC, Nordeng H. Risk perception, beliefs about medicines and medical adherence among pregnant and breastfeeding women with migraine: findings from a cross-sectional study in Norway. BMJ Open 2019;9:e026690. https://doi.org/10.1136/bmjopen-2018-026690.
  7. Gallinger ZR, Rumman A, Nguyen GC. Perceptions and attitudes towards medication adherence during pregnancy in inflammatory bowel disease. J Crohns Colitis. 2016;10:892-7. https://doi.org/10.1093/ecco-jcc/jjw052.
  8. Nyholm RS, Andersen JT, Vermehren C, Kaae S. Perceptions of medicine use among pregnant women: an interview-based study. Int J Clin Pharm. 2019;41:1021-30. https://doi.org/10.1007/s11096-019-00840-4.
  9. Wolgast E, Lindh-Åstrand L, Lilliecreutz C. Women’s perceptions of medication use during pregnancy and breastfeeding-A Swedish cross-sectional questionnaire study. Acta Obstet Gynecol Scand. 2019;98:856-64. https://doi.org/10.1111/aogs.13570.
  10. Van Gelder MMHJ, Rog A, Bredie SJH, Kievit W, Nordeng H, van de Belt TH. Social media monitoring on the perceived safety of medication use during pregnancy: A case study from the Netherlands. Br J Clin Pharmacol. 2019;85:2580-90. https://doi.org/10.1111/bcp.14083.
  11. Bakkebø T, Widnes SF, Aamlid SS, Schjøtt J. Physicians’ perception of teratogenic risk and confidence in prescribing drugs in pregnancy-Influence of Norwegian Drug Information Centers. Clin Ther. 2016;38:1102-8. https://doi.org/10.1016/j.clinthera.2016.02.018.
  12. Widnes SF, Schjøtt J. Risk perception regarding drug use in pregnancy. Am J Obstet Gynecol. 2017;216:375-8. https://doi.org/10.1016/j.ajog.2016.12.007.
  13. Nugraheni G, Sulistyarini A, Zairina E. Beliefs about medicines in pregnancy: a survey using the beliefs about medicines questionnaire in Indonesia. Int J Clin Pharm. 2020;42:57-64. https://doi.org/10.1007/s11096-019-00937-w.
  14. Olesen, C, Søndergaard C, Thrane N, Nielsen GL, de Jong-van den Berg L, Olsen J. Do pregnant women report use of dispensed medications? Epidemiology. 2001;12:497-501. https://doi.org/10.1097/00001648-200109000-00006.
  15. Cheung K, El Marroun H, Elfrink ME, Jaddoe VWV, Visser LE, Stricker BHC. The concordance between self-reported medication use and pharmacy records in pregnant women. Pharmacoepidemiol Drug Saf. 2017;26:1119-25. https://doi.org/10.1002/pds.4264.
  16. De Jonge L, de Walle HEK, de Jong-van den Berg LTW, van Langen IM, Bakker MK. Actual use of medications prescribed during pregnancy: a cross-sectional study using data from a population-based congenital anomaly registry. Drug Saf. 2015;38:737-47. https://doi.org/10.1007/s40264-015-0302-z.
  17. Newport DJ, Brennan PA, Green P, et al. Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation. BJOG. 2008;115:681-8. https://doi.org/10.1111/j.1471-0528.2008.01701.x.
  18. Sarangarm P, Young B, Rayburn W, et al. Agreement between self-report and prescription data in medical records for pregnant women. Birth Defects Res A Clin Mol Teratol. 2012;94:153-61. https://doi.org/10.1002/bdra.22888.
  19. Van Gelder MMHJ, van Rooij IALM, de Walle HEK, Roeleveld N, Bakker MK. Maternal recall of prescription medication use during pregnancy using a paper-based questionnaire: a validation study in the Netherlands. Drug Saf. 2013;36:43-54. https://doi.org/10.1007/s40264-012-0004-8.
  20. Pisa FE, Casetta A, Clagnan E, Michelesio E, Brumatti LV, Barbone F. Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohort. BMC Pregnancy Childbirth. 2015;15:310. https://doi.org/10.1186/s12884-015-0745-3.
  21. Sundermann AC, Hartmann KE, Jones SH, Torstenson ES, Velez Edwards DR. Validation of maternal recall of early pregnancy medication exposure using prospective diary data. Ann Epidemiol. 2017;27:135-9.e2. https://doi.org/10.1016/j.annepidem.2016.11.015.
  22. Van Gelder MMHJ, Vorstenbosch S, te Winkel B, van Puijenbroek EP, Roeleveld N. Using Web-based questionnaires to assess medication use during pregnancy: a validation study in 2 prospectively enrolled cohorts. Am J Epidemiol. 2018;187:326-36. https://doi.org/10.1093/aje/kwx239.
  23. Andrade SE, Bérard A, Nordeng HME, Wood ME, van Gelder MMHJ, Toh S. Administrative claims data versus augmented pregnancy data for the study of pharmaceutical treatments in pregnancy. Curr Epidemiol Rep. 2017;4:106-16. https://doi.org/10.1007/s40471-017-0104-1.
  24. Verbrugge LM. Health diaries. Med Care. 1980;18:73-95. https://doi.org/10.1097/00005650-198001000-00006.
  25. McColl E. Best practice in symptom assessment: a review. Gut. 2004;53(Suppl 4):iv49-54. https://doi.org/10.1136/gut.2003.034355.
  26. Van Gelder MMHJ, Merkus PJFM, van Drongelen J, Swarts JW, van de Belt TH, Roeleveld N. The PRIDE Study: evaluation of online methods of data collection. Paediatr Perinat Epidemiol. 2020;34:484-94. https://doi.org/10.1111/ppe.12618.
  27. KNMP Apothekersorganisatie K. Gebruik van het LSP. https://www.knmp.nl/praktijkvoering/lsp-zorginfrastructuur/gebruik-van-het-lsp. Accessed 13 Jan 2022.
  28. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2021. 2020. https://www.whocc.no/atc_ddd_index/. Accessed 16 March 2021.
  29. Bakker MK, Jentink J, Vroom F, Van Den Berg PB, De Walle HEK, De Jong-Van Den Berg LTW. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG. 2006;113:559-68. https://doi.org/10.1111/j.1471-0528.2006.00927.x.
  30. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691-705. https://doi.org/10.1111/j.1365-2125.2012.04167.x.
  31. Palmsten K, Hulugalle A, Bandoli G, et al. Agreement between maternal report and medical records during pregnancy: medications for rheumatoid arthritis and asthma. Paediatr Perinat Epidemiol. 2018;32:68-77. https://doi.org/10.1111/ppe.12415.
  32. De Jong-van den Berg LTW, Waardenburg CM, Haaijer-Ruskamp FM, Dukes MNG, Wesseling H. Drug use in pregnancy: a comparative appraisal of data collecting methods. Eur J Clin Pharmacol. 1993;45:9-14. https://doi.org/10.1007/bf00315343.
  33. Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol. 2011;3:43-50. https://doi.org/10.2147/clep.s16305.
  34. Espnes MG, Bjørge T, Engeland A. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf. 2011;20:243-8. https://doi.org/10.1002/pds.2085.
  35. Bai L, Zhao D, Cheng Q, et al. Trimester-specific association between antibiotics exposure during pregnancy and childhood asthma or wheeze: the role of confounding. Ann Epidemiol. 2019;30:1-8. https://doi.org/10.1016/j.annepidem.2018.10.003.
  36. Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2019;2019:CD000490. https://doi.org/10.1002/14651858.cd000490.pub4.
  37. Antoun S, Ellul P, Peyre H, et al. Fever during pregnancy as a risk factor for neurodevelopmental disorders: results from a systematic review and meta-analysis. Mol Autism. 2021;12:60. https://doi.org/10.1186/s13229-021-00464-4.
  38. Dreier JW, Nybo Andersen AM, Berg-Beckhoff G. Systematic review and meta-analyses: fever in pregnancy and health impacts in the offspring. Pediatrics. 2014;133:e674-88. https://doi.org/10.1542/peds.2013-3205.
  39. Lupattelli A, Picinardi M, Cantarutti A, Nordeng H. Use and intentional avoidance of prescribed medications in pregnancy: a cross-sectional, Web-based study among 926 women in Italy. Int J Environ Res Public Health. 2020;17:3830. https://doi.org/10.3390/ijerph17113830.
  40. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12:63-8. https://doi.org/10.1089/105072502753451986.
  41. Yland JJ, Bateman BT, Huybrechts KF, et al. Perinatal outcomes associated with maternal asthma and its severity and control during pregnancy. J Allergy Clin Immunol Pract. 2020;8:1928-37.e3. https://doi.org/10.1016/j.jaip.2020.01.016.
  42. Buschur EO, Polsky S. Type 1 diabetes: management in women from preconception to postpartum. J Clin Endocrinol Metab. 2021;106:952-67. https://doi.org/10.1210/clinem/dgaa931.
  43. Santa C, Milheiro Tinoco E, Barreira P, Lima R. Predictive factors of non-adherence to asthma medication in pregnancy. Eur Ann Allergy Clin Immunol. 2021. https://doi.org/10.23822/eurannaci.1764-1489.201.
  44. Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet. 2011;157:175-82. https://doi.org/10.1002/ajmg.c.30313.
  45. Thorpe PG, Gilboa SM, Hernandez-Diaz S, et al. Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiol Drug Saf. 2013;22:1013-8. https://doi.org/10.1002/pds.3495.
  46. Van Gelder MMHJ, de Jong-van den Berg LTW, Roeleveld, N. Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risks. Hum Reprod. 2014;29:168-83. https://doi.org/10.1093/humrep/det370.
  47. Byrne JJ, Saucedo AM, Spong CY. Evaluation of drug labels following the 2015 Pregnancy and Lactation Labeling Rule. JAMA Network Open 2020;3:e2015094. https://doi.org/10.1001/jamanetworkopen.2020.15094.
  48. Caritis SN, Venkataramanan R. Obstetrical, fetal, and lactation pharmacology-a crisis that can no longer be ignored. Am J Obstet Gynecol. 2021;225:10-20. https://doi.org/10.1016/j.ajog.2021.02.002.
  49. Wood ME, Chrysanthopoulou S, Nordeng HME, Lapane KL. The impact of nondifferential exposure misclassification on the performance of propensity scores for continuous and binary outcomes: a simulation study. Med Care. 2018;56:e46-53. https://doi.org/10.1097/mlr.0000000000000800.
  50. Stephansson, O. How to improve information on medication exposure during pregnancy. Paediatr Perinat Epidemiol. 2018;32:78-80. https://doi.org/10.1111/ppe.12431.